
Aakash Desai/LinkedIn
Apr 30, 2025, 07:24
Aakash Desai: Breakthrough device designation for the first AI-driven companion diagnostic in NSCLC
Aakash Desai, Associate Director of Phase 1 and Precision Oncology Program at UAB O’Neal Comprehensive Cancer Center, shared a post on X:
“Breakthrough Device Designation for the first AI-driven companion diagnostic in NSCLC!
VENTANA TROP2 RxDx Device by Roche uses AI + digital pathology to deliver diagnostic precision beyond manual scoring.
Big step forward in precision oncology.”
More posts featuring NSCLC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 30, 2025, 06:41
Apr 30, 2025, 05:52
Apr 30, 2025, 04:15